We determined whether any significant association exists between change in late systolic cardiac load with time, estimated by radial pressure waveform analysis, and development of cardiac hemodynamic stress in individuals with preserved cardiac function.
Central blood pressure and arterial stiffness have been demonstrated to be independent risk factors for cardiovascular disease. 1, 2 Central blood pressure is affected by the forward pressure wave and reflected pressure wave, 3 and it can be estimated by radial pressure waveform analysis. 1, 3 On the other hand, arterial stiffness, estimated by pulse wave velocity (PWV), affects not only the forward pressure wave but also the reflected pressure wave. [3] [4] [5] [6] [7] [8] Recently, the Multiethnic Study of Atherosclerosis (MESA) demonstrated the existence of strong independent associations between the magnitude of reflected pressure wave, estimated by radial pressure wave analysis, and the risk of developing heart failure. 9 Cardiac hemodynamic stress results in left ventricular hypertrophy, thereby serving as a risk factor for new-onset heart failure; 10, 11 it is thought to be a major player in the development of heart failure, even from an early stage. 11, 12 Furthermore, abnormal pulsatile arterial hemodynamics have been demonstrated in individuals with acute heart failure with preserved ejection fraction. 13 While some cross-sectional studies have shown possible associations between late systolic blood pressure and left ventricular hypertrophy and also serum natriuretic peptide levels, 14, 15 which is an important biochemical marker of cardiac hemodynamic stress, [16] [17] [18] [19] it has not yet been clearly determined whether late systolic cardiac load might be associated with the risk of developing heart failure from an early stage. Therefore, we performed this longitudinal study to examine the significance of an association between late systolic cardiac load and early systolic cardiac load and arterial stiffness, as well as the development of cardiac hemodynamic stress.
In the present longitudinal study, we determined whether changes in late systolic cardiac load during the study period, as estimated by radial pressure waveform analysis, may be more closely associated with changes in serum levels of N-terminal fragment B-type natriuretic peptide (NT-proBNP) than with changes in early systolic cardiac load and arterial stiffness in participants with preserved cardiac function.
METHODS

Participants
The participants in this prospective study consisted of a cohort of Japanese employees of a single large construction company. 20 Data were obtained from the annual health checkups for employees received in 2009 and 2012. The checkups, including measurements of brachial-ankle pulse wave velocity (baPWV) and radial augmentation index (radial AI), were conducted in the morning after the participants had fasted overnight. Informed consent was obtained from all study participants prior to joining the study. The study was conducted in compliance with the Declaration of Helsinki and with the approval of the Ethical Guidelines Committee of the Tokyo Medical University. The follow-up protocol is described in detail elsewhere. 20 In 2009, 2,471 participants who were working at the company headquarters underwent annual medical examinations (our previous cross-sectional analysis included participants who worked at the branch offices (n = 2,657)), 15 and 2,267 of these participants were successfully followed up in 2012. However, of these 2,267 participants, 80 were excluded from this study because of the presence of atrial fibrillation, an ankle/brachial systolic blood pressure index of <0.95, or standard deviation of the radial AI of ≥6%. In addition, 22 participants with a history of treatment for heart disease or stroke and all women (n = 314; the number of women was relatively small compared with the number of men) were also excluded. Finally, data for the remaining 1,851 men were included for the analysis.
Measurements
Pulse wave velocity. The baPWV was measured using a volume plethysmographic apparatus (Form/ABI; Colin Co., Ltd., Komaki, Japan), in accordance with a previously described methodology. 20 In brief, the brachial and posttibial arterial pressures were measured using an oscillometric sensor. Measurements were taken after the participants had rested for at least 5 minutes in the supine position in a temperature-controlled room (24°C -26°C) designated exclusively for this purpose. The interobserver and intraobserver coefficients of variation for the baPWV measurements were 8% and 10%, respectively, in our previous study. 21 
Augmentation index.
Blood pressure and radial AI measurements were taken after the participants had rested for at least 5 minutes in the sitting position. Blood pressure was measured in the right upper arm using the oscillometric method (HEM-907; Omron Healthcare Co., Ltd., Kyoto, Japan). Immediately after this measurement was taken, the left radial arterial waveform was recorded using an arterial applanation tonometry probe equipped with an array of 40 micropiezo-resistive transducers (HEM-9000AI; Omron). 22 Then, the first and second peaks of the peripheral systolic blood pressure (SP1 and SP2; a marker of central systolic blood pressure) and peripheral diastolic blood pressure (DBP) were automatically determined using the fourth derivative for each radial arterial waveform and then averaged. The first peak pulse pressure (PP1) and second peak pulse pressure (PP2; a marker of central pulse pressure) were calculated as SP1 minus brachial DBP and SP2 minus brachial DBP, respectively. The radial AI, a marker of central AI, was then calculated as follows: PP2/PP1 × 100 (%). 22 Previously we reported a good reproducibility of the radial AI (Pearson correlation coefficient, 0.95; P < 0.01; coefficient of variation, 3.2%). 22 
Laboratory measurements
Fasting serum concentrations of triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL) cholesterol, creatinine (Cr), and fasting plasma glucose (FPG) concentrations were measured using enzymatic methods (Falco Biosystems Co., Ltd., Tokyo, Japan). Serum NT-proBNP levels were determined using a chemiluminescence immunoassay kit (Roche Diagnostics, Mannheim, Germany). 23 Sensitivity was 88% and specificity was 92%; the interobserver and intraobserver coefficients of variation were 1.8% and 1.6%, respectively. All blood samples were obtained in the morning after the participants had fasted overnight.
Statistical analyses
Data are expressed as mean ± standard deviation. Because the serum NT-proBNP levels were skewed to the right, the values were log-transformed for analyses. Changes in the study variables during the study period were calculated as the values at the second examination minus the values at the first examination. The differences in the measured values between the first and second examinations were assessed using the paired t test.
The relationships among the variables were assessed by univariate and multivariate linear regression analyses. In addition, a stepwise multivariate linear regression analysis was performed to assess the extent of influence of arterial stiffness and central hemodynamics on serum NT-proBNP levels. The covariates used in the basic adjustment model were age, body mass index, smoking status, alcohol intake, TC, HDL, TG, FPG, Cr, heart rate, and history of medication for hypertension, dyslipidemia, and/or diabetes mellitus.
All analyses were conducted using IBM/SPSS software (17.0J for Windows, IBM/SPSS Inc., Chicago, IL). A P value < 0.05 was considered to be indicative of a statistically significant difference. Table 1 , values of PP2, radial AI, baPWV, and serum NT-proBNP level were significantly higher at the second examination compared with values from the first examination.
RESULTS
As shown in
As shown in Table 2 , multivariate linear regression analysis conducted using the basic adjustment model identified not only parameters of radial pressure waveform analysis (i.e., radial AI, SP2, and PP2) but also the baPWV was significantly associated with the log-transformed values of serum NT-proBNP levels at both the first and second examinations.
Furthermore, stepwise multivariate linear regression analysis also demonstrated that among the parameters of the radial pressure waveform analysis and markers of arterial stiffness, only PP2 was most closely associated with serum NT-proBNP levels at both examinations (Table 2 ). Even when the mean blood pressure was added as an additional covariate, PP2 was found to be a significant determinant (at the first examination: unstandardized coefficient = 0.014, standard error = 0.002, standardized coefficient = 0.146, P < 0.001; at the second examination: unstandardized coefficient = 0.024, standard error = 0.002, standardized coefficient = 0.274, P < 0.001).
Change in PP2 was significantly associated with change in serum NT-proBNP level during the study period (Table 3) . A stepwise multivariate linear regression analysis demonstrated that among the parameters of radial pressure waveform analysis and markers of arterial stiffness, only change in PP2 was significantly associated with change in serum NT-proBNP level (Table 3) . Even when change in mean blood pressure during the study period was added as an additional covariate, PP2 was found to be a significant determinant (unstandardized coefficient = 0.433, standard error = 0.081, standardized coefficient = 0.131, P < 0.001). Similar findings were obtained when the analyses were conducted after excluding participants who were being treated for hypertension (n = 1,564).
At the second examination, 263 participants were receiving medication for hypertension. While significantly lower values of brachial blood pressure and SP2 were observed in these individuals at the second examination as compared with values at the first examination, the PP2 did not change. In addition, significantly higher serum NT-proBNP levels were observed at the second examination as compared with the values at the first examination (Table 4) .
DISCUSSIOn
We conducted a longitudinal investigation of the effects of late systolic cardiac load on serum NT-proBNP levels in healthy Japanese middle-aged participants. Abbreviations: β, standardized coefficient; Δ, change in value of variable during study period (covariates in the adjustment model were the delta change of the body mass index, smoking status, total cholesterol, high-density lipoprotein cholesterol, tryglycerides, fasting plasma glucose, creatinine, heart rate, and history of medication for hypertension, dyslipidemia, and/or diabetes mellitus during the follow-up period); B, unstandardized coefficient; SE, standard error. Abbreviations: β, standardized coefficient; B, unstandardized coefficient; baPWV, brachial-ankle pulse wave velocity; logNT-proBNP, logtransformed value of the serum NT-proBNP level (covariates in the basic adjustment model were age, body mass index, smoking status, alcohol intake, total cholesterol, high-density lipoprotein cholesterol, tryglycerides, fasting plasma glucose, creatinine, heart rate, and history of medication for hypertension, dyslipidemia and/or diabetes mellitus); PP1, first peak radial pulse pressure; PP2, second peak radial pulse pressure (second peak of the radial pressure waveform -diastolic blood pressure); rAI, radial augmentation index; SE = standard error; SP1, first peak of the radial pressure waveform; SP2, second peak of the radial pressure waveform.
It has been demonstrated that BNP, a cardiac hormone, is produced mainly in the cardiac ventricles and that its secretion is regulated by the expression level of the gene encoding it. BNP mRNA levels increase in response to various stimuli such as mechanical stress, ischemia, cytokines, and neurohumoral factors; 16, 17, 24 among these, mechanical stress is a major factor. 16, 17, 24 Thus, blood natriuretic peptide levels are increased in patients with left ventricular hypertrophy, and it has been suggested that measurement of the serum natriuretic peptide level can be used as a screening test to detect left ventricular hypertrophy in individuals with hypertension. 25 Cardiac hemodynamic stress results in the development of left ventricular hypertrophy; 12,13 therefore, the blood natriuretic peptide level can also be considered a marker of cardiac hemodynamic stress. [16] [17] [18] [19] The baPWV reflects the stiffness of the large-to middle-sized arteries, 15, 20 and stiffness, especially aortic stiffness, affects not only early systolic cardiac load via elevation of the forward pressure wave but also the late systolic cardiac load by causing earlier return of the reflected pressure wave. [4] [5] [6] [7] [8] Therefore, both SP1 and baPWV are related to early systolic cardiac load. On the other hand, SP2 and PP2 are markers reflecting the late systolic cardiac load. [4] [5] [6] [7] [8] In this longitudinal study, we are the first to demonstrate that change in PP2 over time, rather than change in SP1 or baPWV, was significantly associated with change in serum NT-proBNP level over the same time period. Thus, late systolic cardiac load may be a more significant factor that contributes to cardiac hemodynamic stress than early systolic cardiac load or arterial stiffness.
Recent cross-sectional studies have demonstrated that late systolic wall stress is associated with left ventricular hypertrophy as well as cardiac systolic/diastolic dysfunction. 5, 6, 13 These findings suggest that late systolic cardiac load is an important risk factor not only for the development of left ventricular hypertrophy but also for deterioration of cardiac functions. Kobayashi et al. demonstrated in an animal study that sustained late systolic load is a causal factor for concentric left ventricular hypertrophy, 26 and Hashimoto et al.
reported that reduction in late systolic load is an important therapeutic strategy for achieving regression of left ventricular hypertrophy. 27 However, no clinical prospective study has been performed to confirm that sustained late systolic load is a determinant of the development of cardiac dysfunction. MESA demonstrated that abnormal central hemodynamics, especially magnitude of the reflected pressure wave, is a strong independent risk factor for new-onset heart failure. 9 On the other hand, recent studies have demonstrated that elevated circulating BNP and NT-proBNP levels, even within the normal range, are risk factors not only for future cardiovascular events but also for development of heart failure in the general population. 18, 19, 28 Taken together, the results of the present study indicate that change in PP2 during the study period was associated with change in serum NT-proBNP level during the study period; this is consistent with the concept that late systolic cardiac load is a determinant of development of cardiac systolic and diastolic dysfunction.
Some researchers have reported that central systolic blood pressure is a determinant of the development of left ventricular hypertrophy. 14, 29 However, in patients receiving medication for hypertension, despite significant decrease in brachial blood pressure and SP2, a marker of central pulse pressure, from the first to the second examination caused by antihypertensive treatment. Then, PP2, a marker of the central pulse pressure, did not change and the serum NT-proBNP level increased significantly. Furthermore, in the overall study population, changes in central pulse pressure, as reflected by PP2, rather than changes in central systolic blood pressure, as reflected by SP2, were more closely associated with changes in serum NT-proBNP levels during the study period. We propose the following plausible explanation for these findings. Chirinos et al. reported that the magnitude of the reflected pressure wave rather than AI or pulse pressure amplification was strongly predictive of new-onset heart failure and concluded that the arterial pressure wave reflection is a determinant of the risk of heart failure. 9 Our findings might Serum level of N-terminal fragment of B-type natriuretic peptide, pg/ml 37 ± 2 43 ± 3* a Second peak of the radial pressure waveform -diastolic blood pressure. *P < 0.01 vs. value at first examination as assessed using a paired t test.
be consistent with the findings of Chirinos and colleagues because earlier pressure wave reflection was the major factor associated with elevation in central pulse pressure. 30 Our study had some limitations. We did not assess the association between changes in magnitude of the reflected pressure wave and those of the serum NT-proBNP levels. Further studies are needed to confirm study results in women, patients of other ethnicities, and/or patients with marked increase in arterial stiffness/abnormal central hemodynamics. While measurement of baPWV and radial arterial wave analyses are sufficiently simple to apply to a large population, 15, 20 the carotid-femoral PWV and carotid arterial wave indices are used as the gold standards for assessment of arterial stiffness and central hemodynamics. 2 However, several studies have demonstrated that both are reliable predictors of future cardiovascular events. 1, 31 On the other hand, Ding et al. reported that the central-to-brachial pulse pressure ratio obtained with an OMRON device is lower than that obtained using invasive catheterization. 32 Therefore, confirmation of the significance of the association between central pulse pressure and serum NT-proBNP levels using the invasive catheterization method to measure the former is proposed. Recently, myocardial-arterial coupling, which means that late systolic wall stress is lower than early systolic wall stress relative to the pressure, has been proposed for the protection of cardiomyocytes against excessive late systolic stress. 33 This mechanism is thought to fail in the presence of concentric remodeling or in the early stages of myocardial/left ventricular systolic dysfunction. However, we could not evaluate the effects of these pathophysiological abnormalities on the association of central pulse pressure with the serum NT-proBNP levels in this study.
COnCLUSIOnS
Among the parameters of radial pressure waveform analysis and markers of arterial stiffness, PP2 was found to be the most closely associated with changes in serum NT-proBNP levels during the study period in middle-aged apparently healthy Japanese men. Sustained late systolic cardiac load might be a more significant determinant of the development of cardiac hemodynamic stress than sustained early systolic cardiac load or arterial stiffening in patients with preserved cardiac function.
